GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,075 Cr | ₹1,219 Cr | ₹908 Cr | ₹972 Cr | ₹700 Cr |
What is the latest Short Term Loans and Advances ratio of GLENMARK PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹1,075 Cr |
| Mar2024 | ₹1,219 Cr |
| Mar2023 | ₹908 Cr |
| Mar2022 | ₹972 Cr |
| Mar2021 | ₹700 Cr |
How is Short Term Loans and Advances of GLENMARK PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,075 Cr | -11.83 | |
| Mar2024 | ₹1,219 Cr | 34.26 | |
| Mar2023 | ₹908 Cr | -6.63 | |
| Mar2022 | ₹972 Cr | 38.82 | |
| Mar2021 | ₹700 Cr | - | |
Compare Short Term Loans and Advances of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹57,453.1 Cr | -0.8% | 4.2% | 30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.8% |
4.2% |
30.2% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses